2010 Methodology & Stakeholder Review

Report describing the methodology for the 2010 Access to Medicine Index and how it was developed.

The report includes a set of ambitious, yet achievable expectations for company behaviour in each area measured by the Index.

This report sets out the methodology that underpins the Access to Medicine Index 2010. The Index will be the result of the evaluation and ranking of worldʼs largest pharmaceutical companies and will be published in June 2010.

To formulate the 2010 Index methodology, we used a multi-stakeholder approach, calling on experts from academia, governments, intergovernmental organizations, institutional investors, non-governmental organizations and the pharmaceutical industry. These consultations were then formalized in an extensive Methodology Review Process consisting of three phases.

Sign up to receive updates about our work.